Yang Dong

4PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 05, 2022
First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti-PD-L1 Antibody ZKAB001.

Yan Zhou, Qingcheng Yang, Yang Dong

|Jun 08, 2017
MicroRNA-16-5p Inhibits Osteoclastogenesis in Giant Cell Tumor of Bone.

Shang Sang, Zhichang Zhang, Shu Qin

Pageof 1